Experimentica Ltd. Announced Relocation of U.S. Laboratory Operations to Fort Worth, Texas

Authors' picture

By Experimentica on March 18, 2021

Summary: The relocation will strengthen Experimentica’s position as the premier preclinical ophthalmic CRO. It will also boost innovation capabilities through Industry-Academia collaboration, and support the Company’s growth in North America and globally.

The image shows HSC and mentions Experimentica's latest press release


3 min. to read

Forest Park, IL – March 18, 2021. Experimentica Ltd., a leading contract research organization (CRO) in preclinical ophthalmic drug discovery services, today announced that it has completed the relocation of its U.S. laboratories to Fort Worth, Texas.

In a strategic move to meet the needs of emerging biotech companies and expand industry-academia collaboration, Experimentica entered into a facility agreement with The University of North Texas Health Science Center at Fort Worth, Texas (HSC). The expanded laboratory space will support the company’s anticipated future growth in North America and globally, and provide greater capacity for in vivo studies and the development of new ocular models.

HSC’s growing research portfolio, commitment to drug discovery, and state-of-the-art laboratories make the University an ideal partner for a global CRO. HSC also is home to the North Texas Eye Research Institute (NTERI), an international leader in new discoveries through basic and clinical eye research.

Giedrius Kalesnykas, Ph.D., President and CEO of Experimentica Ltd., remarked, “Our new R&D facility will enable Experimentica to grow to the next level, as we look to further develop our pipeline of ocular models available in the U.S. The Dallas-Fort Worth region is home to many innovative biotech and pharmaceutical companies, as well as world-renowned academic teams in the field of Ophthalmology, including North Texas Eye Research Institute. As the demand for preclinical outsourcing services is increasing due to Covid-19, this move will help improve Experimentica’s position as the preclinical CRO of choice in Ophthalmology in North America and globally.”

“We are truly excited to partner with HSC and the Department of Laboratory Animal Medicine who have a proven track record in vivarium operations and animal welfare. Our expanded preclinical services in HSC’s AAALAC-accredited vivarium will address the emerging need for pharmacokinetic and pharmacological efficacy studies in ocular drug discovery”, Simon Kaja, Ph.D., Chief Scientific Officer and Vice-President, Americas commented.

Brian Gladue, Ph.D., HSC Vice President for Research and Innovation, said “We welcome Experimentica Ltd. to HSC and are excited to partner with a company committed to advancing ophthalmic drug discovery around the world.”

About Experimentica Ltd.

Experimentica Ltd. is a global contract research organization (CRO) that specializes in preclinical models of ophthalmic disease. Our world-class scientists and technicians apply a comprehensive set of skills and industry experience to model ocular diseases using multiple experimental platforms, from cell culture-based systems to complex surgical techniques in preclinical models. With research laboratory operations in Kuopio (Finland), Vilnius (Lithuania), and Fort Worth, Texas (USA), global representation and an industry-leading portfolio, Experimentica Ltd. delivers the highest quality science to clients around the globe by helping advance their ophthalmic drug discovery and drug development portfolio.

Learn more about Experimentica at www.experimentica.com

About The University of North Texas Health Science Center

The University of North Texas Health Science Center (HSC) at Fort Worth is one of the nation’s premier graduate academic institutions, dedicated to education, research, patient care and service. Our growing campus is located in Fort Worth’s Cultural District.

Learn more about HSC at www.unthsc.edu

About The North Texas Eye Research Institute

The North Texas Eye Research Institute (NTERI) is devoted to combating the causes of vision impairment, through the NTERI Mission to (1) perform collaborative, interdisciplinary translational research, (2) educate and train future vision researchers and clinicians, (3) increase vision health in our community through free vision screening and education activities, (4) provide high quality vision health care through our eye clinic.

Learn more about HSC at www.unthsc.edu/north-texas-eye-research-institute

Contact for media enquiries


Guillaume Demarne, Pharm.D., Director, Business Development
Email: gd@experimentica.com
Phone: +33 (0) 7 83 55 69 52

Simon Kaja, Ph.D., Chief Scientific Officer and Vice-President, Americas
Email: kaja@experimentica.com
Phone: +1 (682) 234-4763

The University of North Texas Health Science Center

Alexander Branch, Press Officer, Senior Director of Communications
Email: alexander.branch@unthsc.edu
Phone: +1 (817) 735-2446

Authors' picture